RxDoctor Payments Data

Allison Medlin, MD

Family Medicine · Independence, MONPI 1508018128

Payments from drug & device makers

$4,158in general payments, 2019–2025

Across 274 payments — averaging $15.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$587
  • Boehringer Ingelheim$524
  • AstraZeneca$438
  • Lilly USA, LLC$381
  • GSK$336
  • AbbVie$326
  • plus $2K from 22 others

What the payments were for

  • Food & beverage$4,158100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,158 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$19,153
Medicare patients
43
Services billed
389

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin59$74,903
MounjaroTirzepatide31$50,171
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$45,182
EliquisApixaban35$35,069
ProliaDenosumab19$33,127
Breztri AerosphereBudesonide/Glycopyr/Formoterol23$28,624
MyrbetriqMirabegron31$26,351
RybelsusSemaglutide16$25,030
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr34$21,822
OzempicSemaglutide11$21,616
Stiolto RespimatTiotropium Br/Olodaterol Hcl17$12,206
ArexvyRsvpref3 Antigen/As01e/Pf38$9,470
Albuterol Sulfate HfaAlbuterol Sulfate155$6,040
AbrysvoRsv Vacc, Pref A And Pref B/Pf14$4,235
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$4,035

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat$524$87,10976 claims
GSKTrelegy Ellipta, Anoro Ellipta, Arexvy$336$76,473111 claims
Lilly USA, LLCMounjaro$381$50,17131 claims
Novo NordiskRybelsus, Ozempic$587$46,64627 claims
PfizerEliquis, Abrysvo$232$39,30349 claims
AmgenProlia$184$33,12719 claims
AstraZenecaBreztri Aerosphere$438$28,62423 claims
Astellas Pharma US IncMyrbetriq$167$26,35131 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Independence

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →